 | • レポートコード：MRC2-11QY13584 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は成人T細胞白血病/リンパ腫治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、幹細胞移植、標的療法、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別成人T細胞白血病/リンパ腫治療の競争状況、市場シェア ・世界の成人T細胞白血病/リンパ腫治療市場：種類別市場規模 2015年-2020年（化学療法、幹細胞移植、標的療法、その他） ・世界の成人T細胞白血病/リンパ腫治療市場：種類別市場規模予測 2021年-2026年（化学療法、幹細胞移植、標的療法、その他） ・世界の成人T細胞白血病/リンパ腫治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の成人T細胞白血病/リンパ腫治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の成人T細胞白血病/リンパ腫治療市場分析：米国、カナダ ・ヨーロッパの成人T細胞白血病/リンパ腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの成人T細胞白血病/リンパ腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の成人T細胞白血病/リンパ腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの成人T細胞白血病/リンパ腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Kyowa Kirin、Daiichi Sankyo、Seattle Genetics Inc.、miRagen Therapeutics、Celgene (Bristol-Myers Squibb)、HUYA Bioscience International ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, and smoldering forms) defined by the presenting features, and therefore, the clinical course can vary. For the smoldering and lower-risk chronic forms, combinations involving antiviral therapies have shown some success. However, in many patients, the more indolent forms will evolve into the more aggressive subtypes. In the more aggressive acute, lymphoma, and higher-risk chronic forms, the literature supports initial treatment with combination chemotherapy followed by allogeneic transplantation as a potentially curative approach.
The classification of Adult T-Cell Leukemia/Lymphoma Treatment includes Chemotherapy, Stem Cell Transplantation, Targeted Therapy and others, and the market size proportion of Chemotherapy in 2019 is about 65%.
Adult T-Cell Leukemia/Lymphoma Treatment are used in hospitals, clinics and others. The most proportion of Adult T-Cell Leukemia/Lymphoma Treatment is used in hospitals and the proportion in 2019 is about 70%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 62% in 2019. Following Asia-Pacific, Europe are also very important market with the consumption market share of 15.84%.
Market competition is not intense. Kyowa Kirin is the leaders of the industry, and they hold key technologies and patents, with high-end customers, and other companies are just in the clinical stage.
Market Analysis and Insights: Global Adult T-Cell Leukemia/Lymphoma Treatment Market
The global Adult T-Cell Leukemia/Lymphoma Treatment market size is projected to reach US$ 145.4 million by 2026, from US$ 119.6 million in 2020, at a CAGR of 3.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adult T-Cell Leukemia/Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adult T-Cell Leukemia/Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adult T-Cell Leukemia/Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adult T-Cell Leukemia/Lymphoma Treatment market.
Global Adult T-Cell Leukemia/Lymphoma Treatment Scope and Market Size
Adult T-Cell Leukemia/Lymphoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Adult T-Cell Leukemia/Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Chemotherapy
Stem Cell Transplantation
Targeted Therapy
Others
Market segment by Application, split into
Hospitals
Clinics
Others
Based on regional and country-level analysis, the Adult T-Cell Leukemia/Lymphoma Treatment market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Adult T-Cell Leukemia/Lymphoma Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Kyowa Kirin
Daiichi Sankyo
Seattle Genetics Inc.
miRagen Therapeutics
Celgene (Bristol-Myers Squibb)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Chemotherapy
1.2.3 Stem Cell Transplantation
1.2.4 Targeted Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Perspective (2015-2026)
2.2 Global Adult T-Cell Leukemia/Lymphoma Treatment Growth Trends by Regions
2.2.1 Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Adult T-Cell Leukemia/Lymphoma Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adult T-Cell Leukemia/Lymphoma Treatment Players by Market Size
3.1.1 Global Top Adult T-Cell Leukemia/Lymphoma Treatment Players by Revenue (2015-2020)
3.1.2 Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Adult T-Cell Leukemia/Lymphoma Treatment Revenue
3.4 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adult T-Cell Leukemia/Lymphoma Treatment Revenue in 2019
3.5 Key Players Adult T-Cell Leukemia/Lymphoma Treatment Area Served
3.6 Key Players Adult T-Cell Leukemia/Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Adult T-Cell Leukemia/Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adult T-Cell Leukemia/Lymphoma Treatment Breakdown Data by Type (2015-2026)
4.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Historic Market Size by Type (2015-2020)
4.2 Global Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Type (2021-2026)
5 Adult T-Cell Leukemia/Lymphoma Treatment Breakdown Data by Application (2015-2026)
5.1 Global Adult T-Cell Leukemia/Lymphoma Treatment Historic Market Size by Application (2015-2020)
5.2 Global Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size (2015-2026)
6.2 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2015-2020)
6.3 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2015-2020)
6.4 North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Japan
7.1 Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Size (2015-2026)
7.2 Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2015-2020)
7.3 Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2015-2020)
7.4 Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
(2015-2020)
(2015-2020)
.4 Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
(2015-2020)
(2015-2020)
.4 Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
.4 Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
8Key Players Profiles
8.1 Kyowa Kirin
8.1.1 Kyowa Kirin Company Details
8.1.2 Kyowa Kirin Business Overview
8.1.3 Kyowa Kirin Adult T-Cell Leukemia/Lymphoma Treatment Introduction
8.1.4 Kyowa Kirin Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020))
8.1.5 Kyowa Kirin Recent Development
8.2 Daiichi Sankyo
8.2.1 Daiichi Sankyo Company Details
8.2.2 Daiichi Sankyo Business Overview
8.2.3 Daiichi Sankyo Adult T-Cell Leukemia/Lymphoma Treatment Introduction
8.2.4 Daiichi Sankyo Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
8.2.5 Daiichi Sankyo Recent Development
8.3 Seattle Genetics Inc.
8.3.1 Seattle Genetics Inc. Company Details
8.3.2 Seattle Genetics Inc. Business Overview
8.3.3 Seattle Genetics Inc. Adult T-Cell Leukemia/Lymphoma Treatment Introduction
8.3.4 Seattle Genetics Inc. Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
8.3.5 Seattle Genetics Inc. Recent Development
8.4 miRagen Therapeutics
8.4.1 miRagen Therapeutics Company Details
8.4.2 miRagen Therapeutics Business Overview
8.4.3 miRagen Therapeutics Adult T-Cell Leukemia/Lymphoma Treatment Introduction
8.4.4 miRagen Therapeutics Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
8.4.5 miRagen Therapeutics Recent Development
8.5 Celgene (Bristol-Myers Squibb)
8.5.1 Celgene (Bristol-Myers Squibb) Company Details
8.5.2 Celgene (Bristol-Myers Squibb) Business Overview
8.5.3 Celgene (Bristol-Myers Squibb) Adult T-Cell Leukemia/Lymphoma Treatment Introduction
8.5.4 Celgene (Bristol-Myers Squibb) Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
8.5.5 Celgene (Bristol-Myers Squibb) Recent Development
8.6 HUYA Bioscience International
8.6.1 HUYA Bioscience International Company Details
8.6.2 HUYA Bioscience International Business Overview
8.6.3 HUYA Bioscience International Adult T-Cell Leukemia/Lymphoma Treatment Introduction
8.6.4 HUYA Bioscience International Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
8.6.5 HUYA Bioscience International Recent Development
9Analyst’s Viewpoints/Conclusions
10Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Disclaimer
10.3 Author Details
Table 1. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Stem Cell Transplantation
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Others
Table 7. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Regions (2015-2020)
Table 11. Global Adult T-Cell Leukemia/Lymphoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Regions (2021-2026)
Table 13. Adult T-Cell Leukemia/Lymphoma Treatment Market Market Trends
Table 14. Adult T-Cell Leukemia/Lymphoma Treatment Market Drivers
Table 15. Adult T-Cell Leukemia/Lymphoma Treatment Market Challenges
Table 16. Adult T-Cell Leukemia/Lymphoma Treatment Market Restraints
Table 17. Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Players (2015-2020)
Table 19. Global Top Adult T-Cell Leukemia/Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adult T-Cell Leukemia/Lymphoma Treatment as of 2019)
Table 20. Global Adult T-Cell Leukemia/Lymphoma Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adult T-Cell Leukemia/Lymphoma Treatment Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Share by Type (2015-2020)
Table 26. Global Adult T-Cell Leukemia/Lymphoma Treatment Revenue Market Share by Type (2021-2026)
Table 27. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Share by Application (2015-2020)
Table 28. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size Share by Application (2021-2026)
Table 30. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Type (2015-2020)
Table 32. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application (2015-2020)
Table 34. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Country (2015-2020)
Table 36. Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Type (2015-2020) (US$ Million)
Table 37. Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Type (2015-2020)
Table 38. Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Application (2015-2020) (US$ Million)
Table 39. Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application (2015-2020)
Table 40. Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (US$ Million) (2015-2020)
Table 41. Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Country (2015-2020)
Table 42. Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Region (US$ Million) (2015-2020)
Table 43. Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Region (2015-2020)
Table 44. Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (US$ Million) (2015-2020)
Table 45. Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Country (2015-2020)
Table 46. Adult T-Cell Leukemia/Lymphoma Treatment Market Size by Country (US$ Million) (2015-2020)
Table 47. Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Country (2015-2020)
Table 48. Kyowa Kirin Company Details
Table 49. Kyowa Kirin Business Overview
Table 50. Kyowa Kirin Product
Table 51. Kyowa Kirin Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 52. Kyowa Kirin Recent Development
Table 53. Daiichi Sankyo Company Details
Table 54. Daiichi Sankyo Business Overview
Table 55. Daiichi Sankyo Product
Table 56. Daiichi Sankyo Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 57. Daiichi Sankyo Recent Development
Table 58. Seattle Genetics Inc. Company Details
Table 59. Seattle Genetics Inc. Business Overview
Table 60. Seattle Genetics Inc. Product
Table 61. Seattle Genetics Inc. Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 62. Seattle Genetics Inc. Recent Development
Table 63. miRagen Therapeutics Company Details
Table 64. miRagen Therapeutics Business Overview
Table 65. miRagen Therapeutics Product
Table 66. miRagen Therapeutics Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 67. miRagen Therapeutics Recent Development
Table 68. Celgene (Bristol-Myers Squibb) Company Details
Table 69. Celgene (Bristol-Myers Squibb) Business Overview
Table 70. Celgene (Bristol-Myers Squibb) Product
Table 71. Celgene (Bristol-Myers Squibb) Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 72. Celgene (Bristol-Myers Squibb) Recent Development
Table 73. HUYA Bioscience International Company Details
Table 74. HUYA Bioscience International Business Overview
Table 75. HUYA Bioscience International Product
Table 76. HUYA Bioscience International Revenue in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020) (US$ Million)
Table 77. HUYA Bioscience International Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Stem Cell Transplantation Features
Figure 4. Targeted Therapy Features
Figure 5. Others Features
Figure 6. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Adult T-Cell Leukemia/Lymphoma Treatment Report Years Considered
Figure 11. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Regions (2021-2026)
Figure 14. Global Adult T-Cell Leukemia/Lymphoma Treatment Market Share by Players in 2019
Figure 15. Global Top Adult T-Cell Leukemia/Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adult T-Cell Leukemia/Lymphoma Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Adult T-Cell Leukemia/Lymphoma Treatment Revenue in 2019
Figure 17. North America Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Adult T-Cell Leukemia/Lymphoma Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Kyowa Kirin Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
Figure 45. Daiichi Sankyo Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
Figure 46. Seattle Genetics Inc. Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
Figure 47. miRagen Therapeutics Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
Figure 48. Celgene (Bristol-Myers Squibb) Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
Figure 49. HUYA Bioscience International Revenue Growth Rate in Adult T-Cell Leukemia/Lymphoma Treatment Business (2015-2020)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
成体幹細胞アッセイの世界市場（～2026年） Market Analysis and Insights: Global Adult Stem Cell Assay Market The global Adult Stem Cell Assay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adult Stem Cell Assay Scope and Market Size Adult Stem Cell Assay marke…- 有毛細胞白血病治療の世界市場（～2026年） Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can…
- 有毛細胞白血病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Hairy Cell Leukemia Therapeutics Market The global Hairy Cell Leukemia Therapeutics market size is projected to reach US$ 90 million by 2026, from US$ 86 million in 2020, at a CAGR of 4.8%% during 2021-2026. Global Hairy Cell Leukemia Therapeutics Scope and Marke…
- B細胞慢性リンパ球性白血病治療の世界市場（～2026年） Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global B-Cell Chronic Lymphocy…
- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…